Evaluation of a Microprocessor-controlled Prosthetic Knee-ankle System (SPCM)
NCT ID: NCT06522646
Last Updated: 2024-07-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
12 participants
INTERVENTIONAL
2018-07-09
2023-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main hypothesis being that wearing the SPCM increases the time spent flat-footed in the various walking situations of everyday life, bringing it closer to that of asymptomatic people.
This is a prospective, multicenter, randomized, cross-over study. The participants are transfemoral amputees who have been fitted with a microprocessor-controlled prosthetic knee for more than 3 months.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of Disability Compensation With the C-LEG COMPACT 2 Knee (Ref. 3C60 et 3C60=ST)
NCT02382991
Contribution of a Clinical Pathway for the Treatment of Hip Prosthesis Infections
NCT02660268
The Effect of Different Microprocessor Knee Prostheses on Mobility and Gait Parameters in Transfemoral Amputees
NCT04966936
Multicentre SMS Study - FR
NCT06640764
Evaluation of Correlations Between Different Walk Tests in Patients With Transfemoral Amputees
NCT02766387
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
SPCM
Patients will be fitted with the SPCM prothesis
SPCM
During a period of 4-6 weeks, patients will live in their usual environment with the SPCM prosthesis
Usual Prosthesis
Patients will be fitted with their usual microprocessor prosthesis
Usual Prothesis
During a period of 4-6 weeks, patients will live in their usual environment with their usual microprocessor prosthesis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
SPCM
During a period of 4-6 weeks, patients will live in their usual environment with the SPCM prosthesis
Usual Prothesis
During a period of 4-6 weeks, patients will live in their usual environment with their usual microprocessor prosthesis
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Person fitted for more than 3 months with a microprocessor-controlled knee support phase and oscillating phase, in accordance with the conditions for reimbursement set out in the LPPR.
* Person with a level of activity according to the International Classification of of Functioning, Disability and Health greater than or equal to d4602 (moving around outside the house and other buildings)
* Person able to understand simple commands, to read and write, and to give their informed consent
* Person who has given informed consent
* Person affiliated to a social security scheme
Exclusion Criteria
* Person of full age subject to a legal protection measure or unable to express consent
* Pregnant or breast-feeding women
* Persons with bilateral amputations
* Person with a neurological or orthopedic pathology with major repercussions on locomotion
* Persons with a ground/knee height of less than 43.5 cm or more than 55 cm
* Persons weighing more than 125 kg
* Foot size less than 24 cm or greater than 30 cm
* Person with a hip disarticulation
* Person without an emergency walking solution
* Person with a suspension fitting with vacuum pump
* Person planning a trip outside Europe or unable to return in less than 24 hours (in case of device failure) for the duration of the protocol.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Union de Gestion des Etablissements des Caisses d'Assurance Maladie - Nord Est
OTHER
Hopital d'instruction des armées Percy (HIA Percy)
UNKNOWN
Proteor Group
INDUSTRY
Direction Générale de l'Armement
UNKNOWN
Institution Nationale des Invalides
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hôpital d'Instruction des Armées (HIA) Percy
Clamart, , France
UGECAM-NE - Institut Régional de Médecine Physique et de Readaptation de Nancy
Nancy, , France
Insitution Nationale des Invalides
Paris, , France
Institut de Biomécanique Humaine Georges Charpak
Paris, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SPCM
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.